21st Century Oncology Holdings Inc. Reports First and Second Quarter 2016 Financial Results
Sep 20, 2016 20:08 pm UTC| Business
FORT MYERS, Fla., Sept. 20, 2016 -- 21st Century Oncology Holdings, Inc. (“21C” or the “Company”), the leading global provider of integrated cancer care (ICC) services, announced today its financial results for the...
Sep 20, 2016 20:05 pm UTC| Business
WASHINGTON, Sept. 20, 2016 -- DuPont Fabros Technology, Inc. (NYSE:DFT), a leading owner, developer, operator and manager of enterprise-class, carrier-neutral, large, multi-tenant wholesale data centers, announced today...
Dermira Licenses DRM04 to Maruho for Hyperhidrosis in Japan
Sep 20, 2016 20:05 pm UTC| Business
Terms include $25 million upfront license payment to DermiraMaruho to fund all development and commercial costs for DRM04 in Japan MENLO PARK, Calif., Sept. 20, 2016 -- Dermira, Inc. (NASDAQ:DERM), a...
Sep 20, 2016 20:05 pm UTC| Business
SAN DIEGO, Sept. 20, 2016 -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced it will...
CareDx Announces Proposed Public Offering of Common Stock
Sep 20, 2016 20:01 pm UTC| Business
BRISBANE, Calif., Sept. 20, 2016 -- CareDx, Inc.(Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...
pSivida Reports Inducement Awards to New President and Chief Executive Officer
Sep 20, 2016 20:01 pm UTC| Business
WATERTOWN, Mass., Sept. 20, 2016 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases, today reported the grant of inducement...
Endocyte to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Sep 20, 2016 20:01 pm UTC| Business
WEST LAFAYETTE, Ind., Sept. 20, 2016 -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that...